Pearls and pitfalls in the diagnosis and management of central nervous system infectious diseases

Seminars in Neurology

Volumn 18, Issue 2, 1998, Pages 185-196

  Roos, Karen L ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b Department of Neurology RG 6 ^*  (United States)

Author keywords

Central nervous system infectious diseases; Encephalitis; Meningitis

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; DEXAMETHASONE; MEROPENEM; VANCOMYCIN;

ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; BACTERIUM IDENTIFICATION; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM TUBERCULOSIS; PARASITE IDENTIFICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TOXOPLASMA; TREATMENT PLANNING; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS MENINGITIS;

EID: 0031958343     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040872     Document Type: Review

References (73)

1. Roos KL. Cerebrospinal fluid. In: Roos KL. Meningitis: 100 maxims in neurology. London: Arnold, 1996: 36-52
2. Conly JM, Ronald AR. Cerebrospinal fluid as a diagnostic body fluid. Am J Med 1983;75:102-106
3. Dougherty JM, Roth RM. Cerebral spinal fluid. Emerg Med Clin North Am 1986;4:281-97
4. Bonadio WA. The Cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J 1992;11:423-432
5. Schmidley JM, Simon RP. Postictal pleocytosis. Ann Neurol 1981; 9:81-84
6. Lennox WB, Merritt HH. The Cerebrospinal fluid in "essential" epilepsy. J Neurol Psychopathol 1936;17:97-106
7. Petito CK, Shaefer JA, Plum F Ultrastructural characteristics of the brain and blood-brain barrier in experimental seizures Brain Res 1977;127:251-267
8. Greenlee JE. Approach to diagnosis of meningitis: Cerebrospinal fluid evaluation. Infect Dis Clin North Am 1990;4:583-98
9. Fishman RA. Composition of the Cerebrospinal fluid. In: Fishman RA, ed. Cerebrospinal fluid in diseases of the nervous system. 2nd ed Philadelphia: W.B. Saunders, 1992:183-252
10. Connolly KJ, Hammer SM. The acute aseptic meningitis syndrome. Infect Dis Clin North Am 1990;4:599-622
11. Rubeiz H, Roos RP. Viral meningitis and encephalitis. Semin Neurol 1992;12:165-177
12. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis 1993;168:888-892
13. Rotbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis 1995;20:971-981
14. McKinney RE, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agmmaglobulinemic patients. Rev Infect Dis 1987;9:334-356
15. Modlin JF, Dagan R, Berlin LE. et al. Focal encephalitis with enterovirus infections. Pediatrics 1991;88:841-845
16. Jadoul C, Goethem JV, Martin JJ. Myelitis due to Coxsackievirus B infection. Neurology 1995:45:1626-1627
17. Yui LA, Gledhill RF. Limb paralysis as a manifestation of coxsackie B virus infection. Dev Med Child Neurol 1991;33:427-438
18. Johnson GM, McAbee GA, Seaton ED, Lipson SM. Suspect value of non-CSF viral cultures in the diagnosis of enteroviral CNS infection in young infants. Dev Med Child Neurol 1992;34: 876-884
19. Bale JF. Meningitis and encephalitis. In: McKendall RR, Stroop WG, eds. Handbook of neurovirology. New York: Marcel Dekker,1994: 141-158
20. Roos KL. Aseptic meningitis. In: Roos KL. Meningitis: 100 maxims in neurology. Arnold: London, 1996: 120-142
21. Rotbart HA, Sawyer MH, Fast S, Lewinski C. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J Clin Microbiol 1994;32:2590-2592
22. Mollaret P. La meningite endothelio-leucocytaire multirecurrente benigne, syndrome nouveau ou maladie nouvelle? (Document cliniques). Rev Neurol 1944;76:57
23. Bruyn G, Straathoff LJ. Raymakers GM. Mollaret's meningitis. Differential diagnosis and diagnostic pitfalls Neurology 1962; 12:745-753
24. Hermans PE, Goldstein NP, Wellman WE. Mollaret's meningitis and differential diagnosis of recurrent meningitis. Am J Med 1972;52:128-139
25. Tedder DG, Ashley R, Tyler KL, Levin MJ. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med 1994;121:334-338
26. Picard FJ, Dekaban GA, Silva J, Rice GPA. Mollaret's meningitis associated with herpes simplex type 2 infection. Neurology 1993;43:1722-1727
27. Yamamoto LJ, Tedder DG, Ashley R, Levin MJ. Herpes simplex virus type 1 DNA in Cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med 1991;325:1082-1085
28. Lakeman FD, Whitley RJ, NIAID-Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995;171:857-863
29. Aksamit AJ. Cerebrospinal fluid in the diagnosis of central nervous system infections. In: Roos KL, ed. Central nervous system infectious diseases andtTherapy. New York: Marcel Dekker. 1997:731-745
30. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic CJ, Van Loon AM The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. J Neural Neurosurg Psychiatry 1996;61:339-345
31. Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170:1586-1589
32. Ishiguro N, Yamada S, Takahashi T, et al. Meningoencephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 1990;79:987-989
33. Ward KN, Gray JJ. Primary human herpesvirus-6 infection is frequently overlooked as a cause of febrile fits in young children. J Med Virol 1994;42 119-123
34. Kondo K, Nagafuji H, Hata A, Tomomori C, Yamanishi K. Association of human herpesvirus-6 infection of the central nervous system with recurrence of febrile convulsions J Infect Dis 1993;167:1197-1200
35. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. J Clin Infect Dis 1995;21: 571-576
36. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356-1360
37. Knox KK, Harrington DP, Carrigan DR Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995;45:288-292
38. Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immun Defic Syndr 1995;9:69-73
39. Caserta MT, Hall CB. Human herpesvirus-6. In: Scheld WM, Whitley RJ, Durack DT, eds Infections of the central nervous system. 2nd ed Philadelphia: Lippincott-Raven, 1997: 129-138
40. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci 1995;92:7440-444
41. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994;7:89-116
42. Bale JF. Viral encephalitis. Med Clin North Am 1993;77:25-42
43. Anon. Arboviral disease-United States, 1994. MMWR 1995;44: 641-644
44. Budka H, Urbanits S, Liberski PP, et al. Subacute measles virus encephalitis: a new and fatal opportunistic infection in a patient with AIDS. Neurology 1996;46:586-587
45. Mustafa MM, Weitman SD, Winick NJ, et al. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 1993;16:654-660
46. Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: a hypothesis for altered immune responses J Infect Dis 1994;170(Suppl 1):S24-31
47. Hughes I. Jenney ME, Newton RW, et al. Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukemia Arch Dis Child 1993;68:775-778
48. Ross LA, Kim KS, Mason WH Jr, Gomperts E. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med 1990;88:313-314
49. Friedland IR, Paris M, Ehreu S, Hickey S, Olsen K, McCracken GH Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993;37:1630-1636
50. Pans MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH. Effect of dexamethasone on therapy of experimental penicillin and cephalosporin-resislant pneumococcal meningitis. Antimicrob Agents Chemother 1994;38:1320-1324
51. Paris MM, Ramilo O, McCracken GH. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1995;39:2171-2175
52. Nau RK, Kaye K. Sachdeva M, Sande ER, Tauber MG. Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother 1994;38:1186-1189
53. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-923
54. Klugman K, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995;39:1988-1992
55. Roos KL. Bacterial meningitis. In: Roos KL, ed. Central nervous system infectious diseases and therapy. New York: Marcel Dekker, 1997: 99-126
56. Kleiman MB, Weinberg GA, Reynolds JK, Alien SD. Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the neeed for early repeat lumbar puncture Pediatr Infect Dis J 1993;12:782-784
57. Saez-Llorens X. Castano E, Garcia R, et al Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children, Antimicrob Agents Chemother 1995;39:937-940
58. Klugman KP, Dagan R. The Meropenem Meningitis Group Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 1995;39:1140-1146
59. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasune therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med 1988;319:964-971
60. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-1531
61. Schaad UB, Lips U, Gnehm HE, et al Dexamethasone therapy for bacterial meningitis in children. Lancet 1993;342:457-461
62. King SM, Law B, Langley JM, et al. Dexamethasone therapy for bacterial meningitis. Better never than late? Can J Infect Dis 1994;5:210-215
63. Wald ER, Kaplan SL, Mason EO, et al. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 1995;95: 21-28
64. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989;8:848-851
65. Kennedy WA, Hoyt MJ, McCracken GH. The role of corticosteroids in children with pneumococcal meningitis. Am J Dis Child 1991;145:1374-1378
66. Roos KL. Therapy of bacterial meningitis. In: Roos KL. Meningitis: 100 maxims in neurology. London: Arnold, 1996: 69-108
67. Qazi SA, Khan MA, Mughal N, et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child 1996;75:482-488
68. Kanra GY, Ozen H, Secmeer G, Ceyhan M, Ecevit Z, Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995;14:490-494
69. Committee on Infectious Diseases. Dexamethasone therapy for bacterial meningitis in infants and children. Pediatrics 1990; 86:130-133
70. Gaillard JL, Abadie V, Chevron G, et al. Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob Agents Chemother 1994;38:1209-1210
71. Leonard JM, Des Prez RM. Tuberculous meningitis. Infect Dis Clin North Am 1990;4:769-787
72. Molavi A, LeFrock JL. Tuberculous meningitis. Med Clin North Am 1985;69:315-331
73. Marra CM, Critchlow CW, Hook EW, Collier AC, Lukehart SA. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995;52:68-72